Actionable news
0
All posts from Actionable news
Actionable news in NBIX: Neurocrine Biosciences, Inc.,

Departure of Directors or Certain

(d) On September30, 2015, the Board of Directors (the Board) of Neurocrine Biosciences, Inc., a Delaware corporation (Neurocrine), upon recommendation of its Nominating / Corporate Governance Committee, appointed George J. Morrow as a member of the Board, effective immediately. Mr.Morrow has been appointed as a Class I director to serve until Neurocrines 2018 annual meeting of stockholders.

Mr.Morrow served as Executive Vice President, Global Commercial Operations at Amgen Inc., a global biotechnology company, from 2003 until his retirement in 2011. He joined Amgen in 2001 as Executive Vice President, Worldwide Sales and Marketing.From 1992 to 2001, Mr.Morrow held executive management and commercial positions within several subsidiaries of Glaxo Wellcome, including Group Vice President for Commercial Operations (U.S.), Managing Director (U.K.), and most recently as President and Chief Executive Officer of Glaxo Wellcome, Inc. (U.S.).

Mr.Morrow currently serves on the board of directors of Otonomy, Inc., a...


More